the relevance of mrd assessment in the clinical management of multiple myeloma (mm) patients
Published 4 years ago • 471 plays • Length 1:33:39Download video MP4
Download video MP3
Similar videos
-
56:37
management of multiple myeloma during covid 19
-
40:47
evaluation of sustained mrd negativity w/ daratumumab-combination regimens in relapsed refractory mm
-
58:04
clinical value of measurable residual disease assessment in multiple myeloma
-
6:23
role of mrd assessment in multiple myeloma
-
1:49
the importance of mrd assessment in myeloma with prof. mateos
-
1:11:05
the utility of mrd testing for myeloma patient treatment and outcomes
-
3:06
what is minimal residual testing in multiple myeloma?
-
3:02
technical tips for reliable mrd assessment in patients with multiple myeloma
-
36:31
iach 2019: state-of-the-art management of multiple myeloma
-
4:10
where does mrd belong as a tool in myeloma?
-
19:41
multiple myeloma: minimal residual disease
-
8:42
assessing mrd in multiple myeloma
-
6:36
impact of mrd assessment on myeloma treatment
-
37:23
predictors of unsustained measurable residual disease negativity in patients with multiple myeloma
-
2:55
multiple myeloma mrd assessment
-
5:49
is minimal residual disease (mrd) testing routinely recommended?
-
4:53
clinical implications of loss of minimal residual disease (mrd) negativity in multiple myeloma
-
7:49
clinical significance of mrd testing in mm
-
4:01
if a myeloma patient has mrd-negative status, does that mean that patient is cured?